Cartesian Therapeutics (RNAC) Revenue (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Revenue of $78,000 for Q1 2026, down 92.9% from $1.1 million a year earlier and down 91.8% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Revenue (2015 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics posted Revenue of $2.8 million, down 92.8% from FY2024.
- Revenue has a five-year compound annual growth rate of -30.0% (FY2020 to FY2025).
- By year, Revenue came in at $38.91 million in FY2024 (+49.6%), $26 million in FY2023 (-76.5%), $110.78 million in FY2022 (+30.2%) and $85.08 million in FY2021 (+412.6%).
- The Q1 2026 figure ranks as the lowest quarterly Revenue since Q4 2024.
- Year over year, Revenue gained in two of the last six quarters, with growth averaging 31.1%.
- The high point for year-over-year Revenue in five years was Q2 2024 (growth of 537.2%); the low point was Q2 2025 (a decline of 99.1%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $947,000 (Q4 2025), $452,000 (Q3 2025) and $298,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 947,000.00 |
| Sep 30, 2025 | 452,000.00 |
| Jun 30, 2025 | 298,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -759,000.00 |
| Sep 30, 2024 | 387,000.00 |
| Jun 30, 2024 | 33.45 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 20.71 Mn |
| Jun 30, 2022 | 39.27 Mn |
| Mar 31, 2022 | 34.00 Mn |
| Dec 31, 2021 | 29.94 Mn |
| Sep 30, 2021 | 24.43 Mn |
| Jun 30, 2021 | 19.66 Mn |
API Access
Cartesian Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();